SPRINT PNS System
Commercial- Indications
- Chronic pain, Post-surgical pain, Post-traumatic pain
Company intelligence / Profile preview
The SPRINT PNS System has demonstrated significant and sustained relief for both chronic and acute pain across multiple large-scale, multi-center clinical trials. Clinical evidence includes improved function, quality of life, reduced opioid use compared to placebo or standard interventional treatments. Recent randomized controlled trials have shown positive primary endpoint data for chronic low back pain. Over thirty peer-reviewed publications support its efficacy in various indications including low back, knee, shoulder, post-amputation neuropathic pains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SPR Therapeutics.